Table 6. – Characteristics of patients with heart failure on discharge.
| In-hospital mortality | 49/273 (17.9%) | |||
|---|---|---|---|---|
| Anticoagulant | 93/206 (45.1%) | |||
| BB | 136/145 (93.8%) | |||
| BB contraindicated for 61/206 (29.6%) | ||||
| ACEI | 72/128 (56.2%) | |||
| ACEI contraindicated for 78/206 (37.9%) | ||||
| ARB | 48/145 (33.1%) | |||
| ARB contraindicated for 61/206 (29.6%) | ||||
| Hydralazine | 27/206 (13.1%) | |||
| Nitrate | 23/206 (11.2%) | |||
| Antiarrhythmics | 30/206 (14.6%) | |||
| Digoxin | 26/206 (12.6%) | |||
| Loop diuretics | 156/206 (75.7%) | |||
| Thiazide diuretics | 26/206 (12.6%) | |||
| Spironolactone | 88/124 (70.9%) | |||
| Spironolactone contraindicated for 82/206 (39.8%) | ||||
| Clinical data on discharge* | SBP, mmHg – md (IQR) | 107.1 ± 18.5 | ||
| DBP, mmHg – md (IQR) | 67.3 ± 12.4 | |||
| HR, beats per minute – md (IQR) | 77.9 ± 14.2 | |||
| Instructions | Smoking cessation† | Yes | 10/27 (37.0%) | |
| No | 17/27 (63.0%) | |||
| Non-applicable | 180/207 (87.0%) | |||
| Not documented | 0/27 (0.0%) | |||
| Weight control | Yes | 122/207 (58.9%) | ||
| No | 8/207 (3.9%) | |||
| Not documented | 77/207 (37.2%) | |||
| Physical exercise | Yes | 119/206 (57.8%) | ||
| No | 16/206 (7.8%) | |||
| Non-applicable | 71/206 (34.5%) | |||
| Referred for rehabilitation† | Not documented | 138/196 (70.4%) | ||
| Yes | 5/196 (2.6%) | |||
| No | 11/207 (5.3%) | |||
| Not documented | 53/196 (27.0%) | |||
| Use of prescribed medications | Yes | 180/206 (87.4%) | ||
| No | 0/206 (0.0%) | |||
| Non-applicable | 26/206 (12.6%) | |||
| Counseling in case of worsening of symptoms | Yes | 141/206 (68.4%) | ||
| No | 3/206 (1.4%) | |||
| Not documented | 62/206 (30.1%) | |||
| Vaccination counseling (Influenza and Pneumococcal) | Yes | 57/207 (27.5%) | ||
| No | 21/207 (10.1%) | |||
| Not documented | 129/207 (62.3%) | |||
| Outpatient follow-up | Yes | 202/207 (97.6%) | ||
| No | 5/207 (2.4%) | |||
| Not documented | 4/207 (1.9%) | |||
| Anticoagulant therapy† | Yes | 53/63 (84.1%) | ||
| No | 1/63 (1.6%) | |||
| Non applicable | 77/140 (55.0%) | |||
| Not documented | 9/63 (14.3%) | |||
BB: beta-blocker; ACEI: angiotensin converting enzyme inhibitors; ARB: angiotensin receptor blocker; HR: heart rate; DBP: diastolic blood pressure; SBP: systolic blood pressure. * Variables as median and 1st and 3rd quartiles [md (IQR)]. † Calculated based on patients to whom this therapy is indicated.